Bio-Therapeutic Impact Award
Forecasted
The Bio-Therapeutic Impact Award from Alex's Lemonade Stand Foundation funds clinical trials of cutting-edge biologic therapies to advance pediatric cancer treatment.
Funder: Alex's Lemonade Stand Foundation
Due Dates (Anticipated): June 2027 (Full application deadline, projected)
Funding Amounts: Up to $1.8 million total over 3 years; maximum $600,000 per year; no indirect costs allowed.
Summary: Supports investigator-initiated clinical trials of promising biologic therapies for childhood cancer, aiming to accelerate breakthroughs in pediatric oncology.
Key Information: This is a forecasted opportunity—dates are projected; check the program page for updates.
Description
The Bio-Therapeutic Impact Award, offered by Alex's Lemonade Stand Foundation (ALSF), is designed to accelerate the development and implementation of clinical trials for innovative biologic therapies targeting childhood cancers. This mechanism supports established investigators seeking to move promising research—such as immunotherapy, gene therapy, and small molecule approaches—into clinical application, especially those projects not currently funded by the NIH. The award emphasizes projects with significant potential for scientific and clinical impact, aiming to improve outcomes for pediatric cancer patients.
